Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Assessment of the Diagnostic Value of [<sup>68</sup>Ga]Ga-FAPI-04 and [<sup>18</sup>F]FDG PET in a PHMG-p-Induced Pulmonary Fibrosis Murine Model.

Diagnostics (Basel, Switzerland)·2026
Same author

Automated Measurement of Effective Radiation Dose by <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Tomography (Ann Arbor, Mich.)·2024
Same author

Recent Progress in Myocardial Perfusion Imaging Techniques.

Nuclear medicine and molecular imaging·2024
Same author

2023 Korean Multidisciplinary Guidelines for Colon Cancer Management: Summary of Radiological Points.

Korean journal of radiology·2024
Same author

<sup>177</sup>Lu Anti-Angiogenic Radioimmunotherapy Targeting ATP Synthase in Gastric Cancer Model.

Antibodies (Basel, Switzerland)·2024
Same author

In Vivo Evaluation of <sup>68</sup>Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model.

Pharmaceutics·2024

相关实验视频

Updated: Jul 11, 2025

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
10:01

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening

Published on: March 31, 2022

3.2K

通过使用T型通道抑制剂进行细胞周期同步来调节FDG吸收.

Joon-Kee Yoon1, Won Jun Kang2

  • 1Department of Nuclear Medicine and Molecular Imaging, Ajou University School of Medicine, Suwon 16499, Republic of Korea.

Cancers
|November 14, 2023
PubMed
概括
此摘要是机器生成的。

米贝弗拉迪尔诱导的细胞周期同步增强了前列腺癌细胞中2-[18F]二氧化糖 (FDG) 的瘤吸收,改善了PET成像中的诊断灵敏度.

关键词:
德国联邦财政总局PETG1 逮捕 逮捕 逮捕这是一种T型通道抑制剂.细胞周期同步的同步.这就是米贝弗拉迪尔的兄弟.

更多相关视频

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
08:52

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Published on: August 16, 2015

19.3K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.4K

相关实验视频

Last Updated: Jul 11, 2025

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
10:01

High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening

Published on: March 31, 2022

3.2K
Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization
08:52

Temporal Tracking of Cell Cycle Progression Using Flow Cytometry without the Need for Synchronization

Published on: August 16, 2015

19.3K
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

27.4K

科学领域:

  • 分子生物学分子生物学
  • 在瘤学瘤学.
  • 放射性药物 放射性药物 放射性药物

背景情况:

  • 研究了T型通道抑制剂mibefradil对细胞周期同步的影响.
  • 评估了mibefradil诱导的同步的潜力,以增强瘤2-[18F]二氧化碳-d-葡萄糖 (FDG) 的吸收.
  • 对体外和体内癌症成像的研究影响.

研究的目的:

  • 为了确定米贝弗拉迪尔能否同步癌细胞以增加FDG吸收.
  • 评估细胞周期阶段与葡萄糖模拟吸收之间的相关性.
  • 用PET成像来评估这种方法的体内疗效.

主要方法:

  • 前列腺癌细胞 (PC-3) 用mibefradil进行治疗以诱导G1停止.
  • 在mibefradil戒断后分析了细胞周期分布.
  • 进行了[3H]脱氧-d-葡萄糖 (DDG) 的细胞吸收和体内FDG PET成像.

主要成果:

  • 米贝弗拉迪尔治疗显著增加了G0/G1细胞分数,后来增加了S相分数.
  • 72小时的米贝弗拉迪尔治疗显著增加了[3H]DDG摄入量,与S阶段正相关.
  • 在体内FDGPET成像显示,在治疗mibefradil后,瘤吸收的显著增加.

结论:

  • 使用mibefradil的细胞周期同步可以增强瘤FDG吸收.
  • 这一策略有望提高临床FDG PET成像的诊断灵敏度.